Navigation Links
ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
Date:10/14/2011

SHANGHAI, Oct. 14, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong today.

ShangPharma's shareholders adopted the following resolutions as ordinary resolutions proposed by the Company:

1. THAT the 2011 Share Incentive Plan, in the form attached as Exhibit A to the Notice of Annual General Meeting to Be Held on October 14, 2011 (the "AGM Notice") and approved by the resolutions of the Company's board of directors passed on August 18, 2011, be and hereby is approved and confirmed, and where necessary ratified and that the date of the board resolutions as the effective date of the 2011 Share Incentive Plan be and hereby is approved, confirmed and ratified and that the directors of the Company be and are hereby authorized to grant Awards to subscribe for or acquire shares of the Company thereunder and to allot, issue or approve transfer or otherwise deal with shares of the Company pursuant to the exercise of Awards granted under the 2011 Share Incentive Plan; and

THAT each director or officer of the Company be and is hereby authorized to take any and every action that might be necessary, appropriate or desirable to effect the foregoing resolution as such director or officer, in his or her absolute discretion, thinks fit.

2. THAT the 2010 Share Incentive Plan, in the form attached as Exhibit B to the Notice of Annual General Meeting to Be Held on October 14, 2011 (the "AGM Notice") and approved by the resolutions of the Company's board of directors passed on December 27, 2010, be and hereby is approved, confirmed and ratified and that the date of the board resolutions as the effective date of the 2010 Share Incentive Plan be and hereby is approved, confirmed and ratified and that the directors of the Company be and are hereby authorized to grant Awards to subscribe for or acquire shares of the Company thereunder and to allot, issue or approve transfer or otherwise deal with shares of the Company pursuant to the exercise of Awards granted under the 2010 Share Incentive Plan; and

THAT each director or officer of the Company be and is hereby authorized to take any and every action that might be necessary, appropriate or desirable to effect the foregoing resolution as such director or officer, in his or her absolute discretion, thinks fit.

About ShangPharma CorporationShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.For further information, please contact: ShangPharma Corporation In Shanghai, China Lan Xie VP of Finance and Investor Relations E-mail: IR@shangpharma.com Christensen In New York, US Kimberly Minarovich, +1 917-533-3268 kminarovich@christensenir.com In Hong Kong Tip Fleming, +852-9212-0684 tfleming@christensenir.com
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ShangPharma Announces Appointment of Benson Tsang as a Member of the Board of Directors and Audit Committee
2. ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011
3. ShangPharma Announces Fourth Quarter and Fiscal Year 2010 Results
4. ShangPharma Corporation Files 2010 Annual Report on Form 20-F
5. ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011
6. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
7. ShangPharma Announces Up to $10 Million Share Repurchase Program
8. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
9. ShangPharma Corporation Announces Resignation of a Director
10. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
11. CEL-SCI Corporation Releases Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Injectables Market and Increasing Usage of Complex Biologics during the Forecast ... ... USD 20 Billion in 2015 to around USD 26 Billion by ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental are ... dental fear and require sedation to receive dental care. The doctors offer three treatment ... from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall Centre ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients ... that achieves results in a fraction of the time as traditional braces – ... Significance Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving multi-billion dollar ... shops –can’t help but be heartened by the industry’s current surge. But another thing ... as “skunk smell.” At last they can simply, safely and effectively end their ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a leading provider of ... management module. Using this new feature, sleep physicians can now predict the likelihood ... positive airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The ...
Breaking Medicine News(10 mins):